• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JMJD1C通过激活肺动脉高压中的糖酵解来促进平滑肌细胞增殖。

JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension.

作者信息

Zhang Chen, Sun Yue, Guo Yingying, Xu Jingjing, Zhao Haiyan

机构信息

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.

Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, China.

出版信息

Cell Death Discov. 2023 Mar 18;9(1):98. doi: 10.1038/s41420-023-01390-5.

DOI:10.1038/s41420-023-01390-5
PMID:36934091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10024756/
Abstract

Pulmonary arterial hypertension (PAH) is a chronic disorder characterized by hyperproliferation of pulmonary arterial smooth muscle cells (PASMCs). JMJD1C, a member of the Jumonji domain containing C (JMJC) histone demethylase family, contributes to cardiovascular dysfunction. However, the role of JMJD1C in PAH remains unknown. Mice were exposed to hypoxia to mimic several features associated with PAH clinically. We found that JMJD1C was highly expressed in the lungs of mice after hypoxia exposure. JMJD1C knockdown ameliorated hypoxia-induced right ventricular remodeling and thickening of the pulmonary arterial wall. PASMC hyperproliferation and resistance to apoptosis in mice exposed to hypoxia were suppressed by JMJD1C inhibition. We demonstrated that JMJD1C silencing reduced glycolytic enzymes (HK2, PGK1 and LDHA) and lactate overaccumulation in the lungs of mice exposed to hypoxia. In vitro, hypoxia-induced hyperproliferation and activated glycolytic processes in mouse PASMCs were impaired by JMJD1C knockdown. In addition, the activation of STAT3 signaling by hypoxia was suppressed by JMJD1C silencing both in vivo and in vitro. The overexpression of STAT3 reversed the inhibitory effect of JMJD1C depletion on proliferation and glycolysis in PASMCs under hypoxia. Thus, JMJD1C induces glycolytic processes by activating STAT3 signaling to promote PASMC proliferation and pulmonary vascular remodeling, suggesting the potential role of JMJD1C in regulating the metabolic program and vascular remodeling in PAH.

摘要

肺动脉高压(PAH)是一种以肺动脉平滑肌细胞(PASMCs)过度增殖为特征的慢性疾病。Jumonji结构域含C(JMJC)组蛋白去甲基化酶家族成员JMJD1C会导致心血管功能障碍。然而,JMJD1C在PAH中的作用尚不清楚。将小鼠暴露于低氧环境以模拟临床上与PAH相关的一些特征。我们发现,低氧暴露后小鼠肺中JMJD1C高表达。敲低JMJD1C可改善低氧诱导的右心室重塑和肺动脉壁增厚。抑制JMJD1C可抑制低氧暴露小鼠的PASMC过度增殖和对凋亡的抵抗。我们证明,敲低JMJD1C可减少低氧暴露小鼠肺中的糖酵解酶(HK2、PGK1和LDHA)和乳酸过度积累。在体外,敲低JMJD1C可损害低氧诱导的小鼠PASMC过度增殖和激活的糖酵解过程。此外,体内和体外实验均表明,敲低JMJD1C可抑制低氧对STAT3信号的激活。STAT3的过表达逆转了JMJD1C缺失对低氧条件下PASMC增殖和糖酵解的抑制作用。因此,JMJD1C通过激活STAT3信号诱导糖酵解过程,以促进PASMC增殖和肺血管重塑,提示JMJD1C在调节PAH的代谢程序和血管重塑中具有潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/440ecc9bb92b/41420_2023_1390_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/511814dae90f/41420_2023_1390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/031a9465bf05/41420_2023_1390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/433dda986f43/41420_2023_1390_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/6c6ad0017a2c/41420_2023_1390_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/366a1aee0167/41420_2023_1390_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/440ecc9bb92b/41420_2023_1390_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/511814dae90f/41420_2023_1390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/031a9465bf05/41420_2023_1390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/433dda986f43/41420_2023_1390_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/6c6ad0017a2c/41420_2023_1390_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/366a1aee0167/41420_2023_1390_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/10024756/440ecc9bb92b/41420_2023_1390_Fig7_HTML.jpg

相似文献

1
JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension.JMJD1C通过激活肺动脉高压中的糖酵解来促进平滑肌细胞增殖。
Cell Death Discov. 2023 Mar 18;9(1):98. doi: 10.1038/s41420-023-01390-5.
2
Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.硒蛋白 P 促进肺动脉高压的发生:可能的新型治疗靶点。
Circulation. 2018 Aug 7;138(6):600-623. doi: 10.1161/CIRCULATIONAHA.117.033113.
3
ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.ADAMTS8 促进肺动脉高压和右心衰竭的发展:一个可能的新治疗靶点。
Circ Res. 2019 Oct 25;125(10):884-906. doi: 10.1161/CIRCRESAHA.119.315398. Epub 2019 Sep 26.
4
Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.晚期糖基化终产物受体在肺动脉高压发病机制中的关键作用。
J Am Heart Assoc. 2013 Jan 16;2(1):e005157. doi: 10.1161/JAHA.112.005157.
5
STIM2 (Stromal Interaction Molecule 2)-Mediated Increase in Resting Cytosolic Free Ca Concentration Stimulates PASMC Proliferation in Pulmonary Arterial Hypertension.STIM2(基质相互作用分子 2)介导的静息细胞浆游离钙浓度增加刺激肺动脉高压中 PASMC 的增殖。
Hypertension. 2018 Mar;71(3):518-529. doi: 10.1161/HYPERTENSIONAHA.117.10503. Epub 2018 Jan 22.
6
Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.平滑肌细胞特异性 FoxM1 控制低氧诱导的肺动脉高压。
Cell Signal. 2018 Nov;51:119-129. doi: 10.1016/j.cellsig.2018.08.003. Epub 2018 Aug 6.
7
FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.成纤维细胞生长因子 12(Fibroblast Growth Factor 12)抑制肺动脉高压中的血管平滑肌细胞重构。
Hypertension. 2020 Dec;76(6):1778-1786. doi: 10.1161/HYPERTENSIONAHA.120.15068. Epub 2020 Oct 26.
8
STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.STARS基因敲除通过抑制肺动脉平滑肌细胞增殖减轻缺氧诱导的肺动脉高压。
Biomed Pharmacother. 2017 Mar;87:397-404. doi: 10.1016/j.biopha.2016.12.126. Epub 2017 Jan 6.
9
3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.3-溴丙酮酸通过抑制糖酵解逆转低氧诱导的肺动脉高压:体外和体内研究。
Int J Cardiol. 2018 Sep 1;266:236-241. doi: 10.1016/j.ijcard.2018.03.104. Epub 2018 May 4.
10
Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.Nur77下调通过Axin2-β-连环蛋白信号通路触发低氧性肺动脉高压小鼠的肺动脉平滑肌细胞增殖和迁移。
Vascul Pharmacol. 2016 Dec;87:230-241. doi: 10.1016/j.vph.2016.11.002. Epub 2016 Nov 15.

引用本文的文献

1
Rewriting the vascular script: epigenetic modifiers as scribes of metabolic reprogramming in pulmonary hypertension.改写血管脚本:表观遗传修饰因子作为肺动脉高压中代谢重编程的书写者
J Mol Med (Berl). 2025 Sep 3. doi: 10.1007/s00109-025-02589-y.
2
The role of lactate metabolism and lactylation in pulmonary arterial hypertension.乳酸代谢和乳酸化在肺动脉高压中的作用。
Respir Res. 2025 Mar 12;26(1):99. doi: 10.1186/s12931-025-03163-3.
3
Roles and mechanisms of histone methylation in vascular aging and related diseases.组蛋白甲基化在血管衰老及相关疾病中的作用和机制

本文引用的文献

1
MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension.M1 巨噬细胞来源的 MMP-10 促进肺血管重构和肺动脉高压。
Int J Biol Sci. 2022 Jan 1;18(1):331-348. doi: 10.7150/ijbs.66472. eCollection 2022.
2
Histone demethylase JMJD1C promotes the polarization of M1 macrophages to prevent glioma by upregulating miR-302a.组蛋白去甲基酶 JMJD1C 通过上调 miR-302a 促进 M1 巨噬细胞极化以预防神经胶质瘤。
Clin Transl Med. 2021 Sep;11(9):e424. doi: 10.1002/ctm2.424.
3
AAV1-Mediated shRNA Knockdown of in Rat Bronchus Attenuates Hypoxia-Induced Pulmonary Artery Remodeling.
Clin Epigenetics. 2025 Feb 23;17(1):35. doi: 10.1186/s13148-025-01842-y.
4
NUPR1 modulates pulmonary embolism progression via smooth muscle cells phenotypic transformation.核仁磷酸蛋白1通过平滑肌细胞表型转化调节肺栓塞进展。
Heliyon. 2024 Oct 3;10(21):e38918. doi: 10.1016/j.heliyon.2024.e38918. eCollection 2024 Nov 15.
5
Histone demethylase JMJD1C advances macrophage foam cell formation and atherosclerosis progression by promoting the transcription of PCSK9.组蛋白去甲基化酶JMJD1C通过促进前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)的转录来促进巨噬细胞泡沫细胞形成和动脉粥样硬化进展。
J Physiol Biochem. 2025 Feb;81(1):123-135. doi: 10.1007/s13105-024-01058-3. Epub 2024 Nov 8.
6
Lactate dehydrogenase A (LDHA)-mediated lactate generation promotes pulmonary vascular remodeling in pulmonary hypertension.乳酸脱氢酶 A(LDHA)介导的乳酸生成促进肺动脉高压中的肺血管重构。
J Transl Med. 2024 Aug 5;22(1):738. doi: 10.1186/s12967-024-05543-7.
7
SOCS5, targeted by miR-155-5p, plays a negative regulatory role in pulmonary hypertension through inhibiting JAK2/STAT3 signaling pathway.SOCS5 通过抑制 JAK2/STAT3 信号通路在肺动脉高压中发挥负调控作用,其靶向作用受 miR-155-5p 调控。
BMC Pulm Med. 2024 Jan 24;24(1):52. doi: 10.1186/s12890-024-02857-6.
8
Fatty Oil of Descurainia Sophia Nanoparticles Improve Monocrotaline-Induced Pulmonary Hypertension in Rats Through PLC/IP3R/Ca Signaling Pathway.南葶苈子油脂纳米粒通过 PLC/IP3R/Ca 信号通路改善野百合碱诱导的大鼠肺动脉高压。
Int J Nanomedicine. 2023 Dec 8;18:7483-7503. doi: 10.2147/IJN.S436866. eCollection 2023.
腺相关病毒1介导的大鼠支气管中[具体基因]的短发夹RNA敲低减轻缺氧诱导的肺动脉重塑。 (注:原文中“of”后面缺少具体基因名称)
Hum Gene Ther. 2021 Aug;32(15-16):796-805. doi: 10.1089/hum.2020.242. Epub 2021 Feb 22.
4
JMJD1C knockdown affects myeloid cell lines proliferation, viability, and gemcitabine/carboplatin-sensitivity.JMJD1C 敲低影响髓系细胞系的增殖、活力和吉西他滨/卡铂敏感性。
Pharmacogenet Genomics. 2021 Apr 1;31(3):60-67. doi: 10.1097/FPC.0000000000000422.
5
Targeting Jak-Stat Signaling in Experimental Pulmonary Hypertension.靶向 Jak-Stat 信号通路治疗实验性肺动脉高压
Am J Respir Cell Mol Biol. 2021 Jan;64(1):100-114. doi: 10.1165/rcmb.2019-0431OC.
6
Screening and Identification of Therapeutic Targets for Pulmonary Arterial Hypertension Through Microarray Technology.通过微阵列技术筛选和鉴定肺动脉高压的治疗靶点
Front Genet. 2020 Jul 22;11:782. doi: 10.3389/fgene.2020.00782. eCollection 2020.
7
The Histone Demethylase JMJD1C Regulates CAMKK2-AMPK Signaling to Participate in Cardiac Hypertrophy.组蛋白去甲基化酶JMJD1C调节CAMKK2-AMPK信号通路以参与心肌肥大。
Front Physiol. 2020 Jun 18;11:539. doi: 10.3389/fphys.2020.00539. eCollection 2020.
8
Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.组蛋白去甲基化酶 JMJD1C 的抑制可减轻血管紧张素 II 诱导的心肌肥厚和纤维化。
J Recept Signal Transduct Res. 2020 Aug;40(4):339-347. doi: 10.1080/10799893.2020.1734819. Epub 2020 Mar 3.
9
Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis.组蛋白去甲基酶 JMJD1C 被 mTOR 磷酸化以激活从头脂肪生成。
Nat Commun. 2020 Feb 7;11(1):796. doi: 10.1038/s41467-020-14617-1.
10
ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.ADAMTS8 促进肺动脉高压和右心衰竭的发展:一个可能的新治疗靶点。
Circ Res. 2019 Oct 25;125(10):884-906. doi: 10.1161/CIRCRESAHA.119.315398. Epub 2019 Sep 26.